Tilray Brands, Inc. (TLRY) Spending and interest coverage
- R&D / revenue · 12 months: Value 0.04%; Formula and calculation Research and development expense / revenue. Period ending 2026-05-31..
- Stock-based compensation / revenue · 12 months: Value 5.02%; Formula and calculation Share-based compensation / revenue. Period ending 2026-05-31..
- Interest coverage · 12 months: Value -2.11×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 0.04% | Research and development expense / revenue. Period ending 2026-05-31. $361.00K ÷ $915.45M × 100 ≈ 0.04% |
| Stock-based compensation / revenue · 12 months | 5.02% | Share-based compensation / revenue. Period ending 2026-05-31. $45.94M ÷ $915.45M × 100 ≈ 5.02% |
| Interest coverage · 12 months | -2.11× | Operating income ÷ reported interest expense. $-63.03M ÷ $29.91M ≈ -2.11× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 361.00K USD | Research and Development Expense |
| Revenue | 915.45M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 45.94M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -63.03M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 29.91M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $361.00K | $915.45M | $45.94M | $-63.03M | $29.91M | 0.04% | 5.02% | -2.11× | Reported |
| 2026-02-28 | $215.00K | $858.27M | $37.16M | $-1.49B | (m) | 0.03% | 4.33% | (m) | (m) |
| 2025-11-30 | $238.00K | $837.32M | $27.47M | $-2.22B | (m) | 0.03% | 3.28% | (m) | (m) |
| 2025-08-31 | $220.00K | $830.77M | $22.42M | $-2.24B | (m) | 0.03% | 2.70% | (m) | (m) |
| 2025-05-31 | $284.00K | $821.31M | $24.29M | $-2.28B | $41.33M | 0.03% | 2.96% | -55.23× | Reported |
| 2025-02-28 | $644.00K | $826.66M | $25.44M | $-855.25M | (m) | 0.08% | 3.08% | (m) | (m) |
| 2024-11-30 | $665.00K | $829.22M | $29.46M | $-177.41M | (m) | 0.08% | 3.55% | (m) | (m) |
| 2024-08-31 | $661.00K | $812.04M | $30.43M | $-176.95M | (m) | 0.08% | 3.75% | (m) | (m) |
| 2024-05-31 | $635.00K | $788.94M | $31.77M | $-174.75M | $49.26M | 0.08% | 4.03% | -3.55× | Reported |
| 2024-02-29 | $421.00K | $743.25M | $34.35M | $-248.20M | (m) | 0.06% | 4.62% | (m) | (m) |
| 2023-11-30 | $486.00K | $700.50M | $35.92M | $-1.37B | (m) | 0.07% | 5.13% | (m) | (m) |
| 2023-08-31 | $595.00K | $650.86M | $38.66M | $-1.38B | (m) | 0.09% | 5.94% | (m) | (m) |
| 2023-05-31 | $682.00K | $627.12M | $39.59M | $-1.37B | $46.61M | 0.11% | 6.31% | -29.38× | Reported |
| 2023-02-28 | $556.00K | $596.26M | $38.73M | $-1.75B | (m) | 0.09% | 6.50% | (m) | (m) |
| 2022-11-30 | $549.00K | $602.54M | $38.46M | $-558.47M | (m) | 0.09% | 6.38% | (m) | (m) |
| 2022-08-31 | $899.00K | $613.56M | $41.11M | $-562.21M | (m) | 0.15% | 6.70% | (m) | (m) |
| 2022-05-31 | $1.52M | $628.37M | $35.99M | $-610.40M | $39.68M | 0.24% | 5.73% | -15.38× | Reported |
| 2022-02-28 | $1.82M | $617.28M | $32.96M | $-216.66M | (m) | 0.30% | 5.34% | (m) | (m) |
| 2021-11-30 | $1.78M | $589.31M | $26.68M | $-220.95M | (m) | 0.30% | 4.53% | (m) | (m) |
| 2021-08-31 | $1.50M | $563.62M | $18.57M | $-192.23M | (m) | 0.27% | 3.30% | (m) | (m) |
| 2021-05-31 | $830.00K | $513.09M | $17.35M | $-132.17M | (m) | 0.16% | 3.38% | (m) | (m) |
| 2021-03-31 | $4.27M | (m) | $29.23M | $-203.18M | (m) | (m) | (m) | (m) | (m) |
| 2021-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $4.41M | (m) | $29.72M | $-201.12M | (m) | (m) | (m) | (m) | (m) |
| 2020-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $4.50M | (m) | $32.94M | $-396.35M | (m) | (m) | (m) | (m) | (m) |
| 2020-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $5.89M | (m) | $33.51M | $-387.37M | (m) | (m) | (m) | (m) | (m) |
| 2020-05-31 | $1.92M | $405.33M | $18.08M | $-104.01M | (m) | 0.47% | 4.46% | (m) | (m) |
| 2020-03-31 | $6.77M | (m) | $33.78M | $-344.51M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $6.56M | (m) | $31.84M | $-301.70M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $6.74M | (m) | $25.32M | $-106.57M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $5.23M | (m) | $28.25M | $-103.31M | (m) | (m) | (m) | (m) | (m) |
| 2019-05-31 | $1.05M | $179.30M | $21.95M | $-138.93M | (m) | 0.59% | 12.24% | (m) | (m) |
| 2019-03-31 | $4.34M | (m) | $26.26M | $-81.78M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $4.26M | (m) | $20.99M | $-57.65M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $-10.85M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $3.17M | (m) | $139.00K | $-7.50M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.14M | (m) | $94.00K | $-7.05M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |